Olympia Pharmacy Recalls Oxytocin Injection Due to Sterility Concerns
Olympia Pharmacy is recalling Oxytocin 20 units/ml Injection because FDA inspections raised concerns about quality control and sterility assurance.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class II, and the hazard involves a lack of assurance of sterility in an injectable drug, which aligns with the rubric criteria for Severe severity involving significant risk factors.
Plain-English summary
Lowlite Investments, Inc. D/B/A Olympia Pharmacy is recalling Oxytocin 20 units/ml Injection. The recall was initiated following FDA inspection findings that resulted in concerns regarding quality control processes and the assurance of sterility for the product.
The affected product consists of three units of Oxytocin 20 units/ml Injection. The specific lot codes and expiration dates are B5019 (Exp 10/31/13), B3525 (Exp 8/25/13), and B3122 (Exp 8/22/13). The product was distributed nationwide and in Puerto Rico.
Consumers and healthcare providers should check their inventory for these specific lot codes and expiration dates. If the product is found, it should be stopped from use and returned to the pharmacy or supplier in accordance with the recall instructions.
The recalled product
- Product
- Oxytocin 20 units/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
- Manufacturer
- Lowlite Investments, Inc. D/B/A Olympia Pharmacy
- Category
- Drug — Injectable
- Affected units
- 3
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- B5019 Exp 10/31/13
- B3525 Exp 8/25/13 and B3122 Exp 8/22/13
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 105 recalled by Lowlite Investments, Inc. D/B/A Olympia Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 105 products in this recall →Related recalls
Same manufacturer · Lowlite Investments, Inc. D/B/A Olympia Pharmacy
See all →- SevereOlympia Pharmacy Recalls Diclazuril Injection Due to Sterility Concerns
FDA (Drugs) · 2013-07-17
- HighOlympia Pharmacy Recalls Metabolase Injection Due to Sterility Concerns
FDA (Drugs) · 2013-07-17
- SevereOlympia Pharmacy Recalls Betamethasone Injection Due to Sterility Concerns
FDA (Drugs) · 2013-07-17
- SevereOlympia Pharmacy Recalls HACC 270.1 Injection Due to Sterility Concerns
FDA (Drugs) · 2013-07-17
- SevereOlympia Pharmacy Recalls ITPP and DMG Injection Due to Sterility Concerns
FDA (Drugs) · 2013-07-17
Same hazard · sterility concern
See all →- HighSegmental Stem Components for ELEOS Limb Salvage System Recalled
FDA (Devices) · 2025-06-04
- HighMEDIHONEY Dressing Applicator Pouch Recalled for Sterility Concerns
FDA (Devices) · 2024-10-16
- HighProparacaine Hydrochloride Eye Drops Recalled Due to Temperature Exposure
FDA (Drugs) · 2024-10-02
- HighExactech OPTETRAK Knee Implants Recalled for Out-of-Specification Vacuum Bag Packaging
FDA (Devices) · 2024-06-26
- HighPantoprazole Sodium for Injection Recalled Due to Sterility Concern
FDA (Drugs) · 2023-09-20